Researchers examine the prevalence of post-infectious irritable bowel syndrome and post-infectious function dyspepsia following acute gastroenteritis.
FDA commissioner hints at cardio-related label expansion for Wegovy, full approval for Lilly’s new Alzheimer’s drug
WASHINGTON — FDA Commissioner Rob Califf took the podium Wednesday afternoon at the National Press Club, offering up more warnings about misinformation leading to declining